Emerging agents and regimens for polycythemia vera and essential thrombocythemia

Polycythemia vera (PV) and essential thrombocythemia (ET) are both driven by JAK-STAT pathway activation and consequently much of the recent research efforts to improve the management and outcomes of patients with these neoplasms have centered around inhibition of this pathway. In addition to newer...

Descripción completa

Detalles Bibliográficos
Autores principales: Shallis, Rory M., Podoltsev, Nikolai A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161993/
https://www.ncbi.nlm.nih.gov/pubmed/34049597
http://dx.doi.org/10.1186/s40364-021-00298-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161993/
https://www.ncbi.nlm.nih.gov/pubmed/34049597
http://dx.doi.org/10.1186/s40364-021-00298-5

Ejemplares similares